Germline mutations in SPATA5 and SPATA5L1 were identified in a spectrum of neurodevelopmental disorders characterized by microcephaly, intellectual disability, seizures, spasticity, hearing loss, and thrombocytopenia13–18. This evidence concerns the gene AFG2A and microcephaly.